Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luxin Yang

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Bone Marrow Transplantation|July 4, 2025
Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteersCe Shi, Xiangjun Zeng, Jimei Ge, et al.
British Journal of Haematology|June 12, 2023
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantationLinnan Wu, Yibo Wu, Jimin Shi, et al.
Cancer|May 20, 2026
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trialXiaoyu Lai, Panpan Zhu, Luxin Yang, et al.
Bone Marrow Transplantation|May 25, 2021
Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysisYishan Ye, Mowang Wang, Florent Malard, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in <i>FLT3</i>-ITD acute myeloid leukemia patients: A multi-center, retrospective studyYeqian Zhao, Chuanhe Jiang, Yi Luo, et al.
Eclinicalmedicine|January 11, 2024
Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trialYi Luo, Lei Gao, Jia Liu, et al.
Cancer|June 18, 2025
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemiaYibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.
Transplantation and Cellular Therapy|August 3, 2025
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World StudyXiaolin Yuan, Lihong Ni, Ting Chen, et al.
Leukemia|October 29, 2024
Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantationWeihao Chen, Lieguang Chen, Yang Cao, et al.
Cell Transplantation|February 12, 2026
Prognostic impact of clinico-genetic characteristics and donor types in <i>NPM1</i>-mutated AML undergoing allogeneic hematopoietic stem cell transplantationXiaolin Yuan, Yibo Wu, Tingting Yang, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Bone Marrow Transplantation|July 4, 2025
Machine learning-based prediction of G-CSF-induced hematopoietic stem cell mobilization outcomes in healthy volunteersCe Shi, Xiangjun Zeng, Jimei Ge, et al.
British Journal of Haematology|June 12, 2023
Survival and late mortality among patients who survived disease-free for 2 years after stem cell transplantationLinnan Wu, Yibo Wu, Jimin Shi, et al.
Cancer|May 20, 2026
Integration of venetoclax into a fludarabine and melphalan conditioning regimen in patients aged 50 years and older with acute myeloid leukemia and myelodysplastic syndrome: Results from a phase 2 clinical trialXiaoyu Lai, Panpan Zhu, Luxin Yang, et al.
Bone Marrow Transplantation|May 25, 2021
Comparison of non-first-degree related donors and first-degree related donors in haploidentical HSCT: a multi-centre retrospective analysisYishan Ye, Mowang Wang, Florent Malard, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 22, 2025
Impact of clinical characteristics and genetic profiles on outcomes of allogeneic stem cell transplantation with sorafenib maintenance in <i>FLT3</i>-ITD acute myeloid leukemia patients: A multi-center, retrospective studyYeqian Zhao, Chuanhe Jiang, Yi Luo, et al.
Eclinicalmedicine|January 11, 2024
Donor-derived Anti-CD19 CAR T cells GC007g for relapsed or refractory B-cell acute lymphoblastic leukemia after allogeneic HSCT: a phase 1 trialYi Luo, Lei Gao, Jia Liu, et al.
Cancer|June 18, 2025
KRAS mutation status critically determines the clinical outcome of patients with KMT2A-rearranged acute myeloid leukemiaYibo Wu, Xiaolin Yuan, Xiaoyu Lai, et al.
Transplantation and Cellular Therapy|August 3, 2025
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World StudyXiaolin Yuan, Lihong Ni, Ting Chen, et al.
Leukemia|October 29, 2024
Validation and refinement of the 2022 European LeukaemiaNet genetic risk classification of acute myeloid leukaemia patients receiving allogeneic haematopoietic cell transplantationWeihao Chen, Lieguang Chen, Yang Cao, et al.
Cell Transplantation|February 12, 2026
Prognostic impact of clinico-genetic characteristics and donor types in <i>NPM1</i>-mutated AML undergoing allogeneic hematopoietic stem cell transplantationXiaolin Yuan, Yibo Wu, Tingting Yang, et al.
Pageof 7